Transforming Health Care in Rare Disease
Konstantinos Lazaridis, M.D.
Eva M. Carmona Porquera, M.D., Ph.D.
Alejandro Ferrer, Ph.D.
Brittany Thomas, M.S., CGC
Filippo Pinto e Vairo, M.D., Ph.D.
Fernando C. Fervenza, M.D., Ph.D.
Mrinal S. Patnaik, M.B.B.S.

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

• Define the landscape of rare disease in the US and at Mayo Clinic
• Explore the approaches of genetic testing for elucidating the etiology of rare disease
• Describe how genetic testing transforms the management of patients with rare disease from different practices

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.